Natural killer cells battle pediatric leukemia
Acute lymphoblastic leukemia (ALL) is the most common cancer of childhood. This disease hinders the development of healthy blood cells while cancer cells proliferate. Currently, children with ALL receive chemotherapy for two to three years, exposing them to significant side effects including changes in normal development and future fertility. As a way to avoid these adverse effects, investigators have been researching how to supercharge the body’s innate cancer-fighting ability — a technique called immunotherapy…